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Introduction
Lennox-Gastaut syndrome (LGS) is one of the most challenging epilepsies to manage, due to a range of different seizure types which are frequently refractory to anti-seizure drug treatment. In patients with drug-resistant epilepsy, treatment options other than anti-seizure drugs are often considered; including epilepsy surgery, vagus nerve stimulation (VNS) therapy and a ketogenic diet.
We report a case of a boy with LGS and drug-resistant epilepsy responding to VNS therapy that is remarkable in several ways.
Case Study
A now 16-year-old boy with a LGS, associated with an ARGHAP35 gene mutation, reached all developmental milestones until the age of 13 months. Then During this surgery, unexpectedly, the entire VNS system had to be replaced because the silicone lead insulation had apparently completely disintegrated over the years (10 years after primary implantation), a well-known complication after prolonged VNS therapy using the older type 302 lead [1] . After surgery, the generator was set to a lower output current (0.625 mA, 30 Hz, 500 µs, 30 s on / 1.8 min off) to prevent sudden overstimulation of an irritated vagus nerve, while skipping the usual two-week stimulation-free interval after (initial) lead implantation. Despite the lower output current, he suffered from frequent vomiting. First, we decreased output current to a very low setting of 0.25 mA, but ultimately we had to switch off VNS 8 days after surgery assuming the vagus nerve was still irritated as other causes for vomiting had been excluded by tapering down anti-seizure drugs, checking relevant blood
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A C C E P T E D M A N U S C R I P T 5 values, an EEG, and a brain CT scan. Interestingly, switching off the VNS resulted in seizure recurrence within one hour, followed three days later by a non-convulsive status epilepticus which was refractory to intravenous midazolam and phenytoin treatment (Figure 1a ). Turning on the VNS (still with an output current of just 0.25 mA) immediately resulted in cessation of the status epilepticus (Figure 1b) Neither the authors nor the producer (LivaNova) have been able to identify why this
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6 dysfunction was not diagnosed during the these checks. Second, this case illustrates one should be very cautious to switch off VNS abruptly, because this can promptly result in seizures and even in (non-convulsive) status epilepticus. Third, while his non-convulsive status epilepticus was refractory to drug therapy, it was immediately halted by re-initiating VNS therapy. Although the effectiveness of VNS therapy for the cessation of refractory status epilepticus has been previously reported [2] , the almost instantaneous seizure reoccurrence followed by a non-convulsive status epilepticus after VNS switch-off, and the rapid cessation 
Figure legends
